Beverly Jaggers
Acute Care · Bowling Green, KYNPI 1336636703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,771 and has fallen 86.1% since, to $246 in 2023. Among acute care clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 222 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$542
- GSK$524
- AstraZeneca$362
- Regeneron Healthcare Solutions, Inc.$260
- Actelion Pharmaceuticals US, Inc.$259
- Sanofi$204
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,64299%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 36 | $542 |
| GSK | 42 | $524 |
| AstraZeneca(2 entities) | 16 | $362 |
| Regeneron Healthcare Solutions, Inc. | 18 | $260 |
| Actelion Pharmaceuticals US, Inc. | 15 | $259 |
| Sanofi | 9 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $161 |
| Jazz Pharmaceuticals Inc. | 8 | $143 |
| Mylan Specialty L.p. | 9 | $134 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Gilead | 8 | $100 |
| Pfizer | 6 | $92 |
| Grifols USA, LLC | 6 | $86 |
| Mallinckrodt Hospital Products Inc. | 3 | $83 |
| Amgen | 5 | $72 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Philips North America LLC | 4 | $63 |
| AbbVie | 4 | $60 |
| Novartis | 3 | $49 |
| Harmony Biosciences LLC | 3 | $41 |
| La Jolla Pharmaceutical Company | 2 | $40 |
| Mayne Pharma Commercial LLC | 2 | $40 |
| Baxter Healthcare | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| United Therapeutics Corporation | 1 | $20 |
| Advanced Respiratory, Inc | 1 | $14 |
| Covis Pharma GmbH | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,671 in reported general payments places this provider in the 90th percentile of 319 acute care providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 15 | $98 |
Paid to pharmacies, not to this prescriber.
Other acute care in Bowling Green
- Shannon AtkinsonBowling Green$63K
- Bonnie StagnerBowling Green$3K
- Martina FeeBowling Green$2K
- Billie WaltersLexington$20K
- Audra MarcumLexington$14K
- Holly ChitwoodLexington$10K
- Vanessa PaddyElizabethtown$8K
- Baylee KnoxGlasgow$8K
- Katherine BeanOwensboro$7K
- Anna BayesAshland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.